The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Have you been in a trial for Pembrolizumab? Please share your experiences

Forums Caregiver Community Have you been in a trial for Pembrolizumab? Please share your experiences

  • Post
    JP.2000
    Participant

      Journey DX, a patient research company, is working with patient advocacy group Canadian Skin Patient Alliance (CSPA) on research to understand the potential impact of pembrolizumab on the patient experience.

      The research will be used as part of the CSPA patient input submission, to advocate for provincial coverage of pembrolizumab in Canada, so that patients may have access to this drug without paying for it out-of-pocket.

      We are conducting telephone interviews (30-45 minutes) with:

      1) Individuals from Canada or the US who have been in a pembrolizumab trial

      2) caregivers for individuals who have been in a pembrolizumab trial

      Absolutely no names or identifying information will be reported.

      A compensation of $50 will be provided to those who participate, in appreciation of their time.

      If you would like to be involved or would simply like more information, please contact Dr. Jennifer Pereira, Research Director of Journey DX ([email protected], 416-485-7387).

      Thank you very much for your consideration.

    Viewing 2 reply threads
    • Replies
        _Paul_
        Participant

          Hi Dr. Pereira. Is this only for people that received pembro in trial as opposed to those who received it as standard of care?

            JP.2000
            Participant

              Hi Paul,

              Thank you for your question –  yes, we're happy to include anyone who has taken pembrolizumab, in a trial or as part of regular care.

              Best,

              Jen 

              JP.2000
              Participant

                Hi Paul,

                Thank you for your question –  yes, we're happy to include anyone who has taken pembrolizumab, in a trial or as part of regular care.

                Best,

                Jen 

                JP.2000
                Participant

                  Hi Paul,

                  Thank you for your question –  yes, we're happy to include anyone who has taken pembrolizumab, in a trial or as part of regular care.

                  Best,

                  Jen 

                _Paul_
                Participant

                  Hi Dr. Pereira. Is this only for people that received pembro in trial as opposed to those who received it as standard of care?

                  _Paul_
                  Participant

                    Hi Dr. Pereira. Is this only for people that received pembro in trial as opposed to those who received it as standard of care?

                Viewing 2 reply threads

                Tagged: 

                • You must be logged in to reply to this topic.
                About the MRF Patient Forum

                The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                Popular Topics